Last reviewed · How we verify

NCT05410756

Relationship Between Dysphonia And Anxiety In Fibromyalgia

Completed Last updated 15 June 2022
What this trial tests

trial testing Assessment of Voice Quality and Function in Dysphonia in 50 participants. Completed in 1 June 2022.

Timeline
1 March 2022
Primary endpoint
1 June 2022
1 June 2022

Quick facts

Lead sponsorUmraniye Education and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 March 2022
Primary completion1 June 2022
Estimated completion1 June 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Umraniye Education and Research Hospital

Who can join

Adults 18 to 70, any sex, with Dysphonia or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our aim in conducting this study is to determine the relationship between voice disorders and anxiety in patients with fibromyalgia syndrome (FS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dysphonia

Currently open trials in the same condition.

Other Umraniye Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing